Xeris Biopharma Holdings, Inc. Common Stock
XERS •
Buy Open
Signal type
Buy
Status
Open
Open Price
$6.15
Stop Loss
$5.70
Performance
-1.22%
Days Open
9
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 6, 2026
Open Price $6.15
Stop Loss $5.70
Timespan Day
Company Profile
Name Xeris Biopharma Holdings, Inc. Common Stock
Ticker XERS
Market Cap $747.92M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $6.07
List Date Jun 21, 2018
Description
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
Website Open Company Website